Anhui Provincial Hospital

This study is testing whether a specific injection can help protect the liver during and after surgery to remove liver cancer. Researchers want to see if giving this injection before surgery, and then alongside another standard medication after surgery, helps patients' liver func…

This early-phase study is testing a new type of cell therapy called Meta10-TIL for people with advanced solid tumors that have stopped responding to standard treatments. Doctors take a patient's own immune cells from a tumor, modify them in a lab to potentially work better, and t…

This study is testing a new combination treatment for people with advanced esophageal cancer that has worsened after their first treatment. It combines an immunotherapy drug called Ivonescimab with a short, intense course of radiation therapy. The main goals are to see if this ap…

This study is testing whether the time of day a patient receives a cord blood stem cell transplant affects their risk of developing a serious complication called acute graft-versus-host disease (GVHD). It will involve 134 adults with blood cancers who are getting their first tran…

This early-stage trial is testing a new stem cell treatment for patients with a severe complication called graft-versus-host disease (GVHD) that doesn't respond to standard steroid treatment. The study will give 12 patients lab-grown stem cells derived from human stem cells to se…

This early study is testing a new treatment called LCAR02, a gene injection designed to target CD19 on cancer cells, in up to 18 adults with B-cell lymphoma that has come back or not responded to standard treatments. The main goals are to check the safety of the treatment and see…

This early-stage study is testing whether infusions of cells from donated umbilical cord blood can help improve or stabilize thinking skills and daily function in people with Alzheimer's disease. Thirty participants with mild to moderate Alzheimer's will receive either a low dose…

This study aims to find the best length of time for kidney transplant patients to take a preventive antibiotic to stop a dangerous lung infection called PJP. Researchers will enroll 450 patients and compare different treatment durations to see which one is most effective at preve…